A multicenter study of CA 125 level as a predictor of non-optimal primary cytoreduction of advanced epithelial ovarian cancer
- 30 November 2005
- journal article
- research article
- Published by Elsevier BV in European Journal of Surgical Oncology
- Vol. 31 (9), 1006-1010
- https://doi.org/10.1016/j.ejso.2005.05.009
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinomaCancer, 2004
- The role of interval debulking surgery in ovarian cancer.Current Oncology Reports, 2003
- Survival Effect of Maximal Cytoreductive Surgery for Advanced Ovarian Carcinoma During the Platinum Era: A Meta-AnalysisJournal of Clinical Oncology, 2002
- A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomographyCancer, 2000
- The Ability of Preoperative Serum CA-125 to Predict Optimal Primary Tumor Cytoreduction in Stage III Epithelial Ovarian CarcinomaGynecologic Oncology, 2000
- Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 PatientsGynecologic Oncology, 1998
- Ovarian carcinoma: value of CT in predicting success of debulking surgery.American Journal of Roentgenology, 1995
- The Effect of Debulking Surgery after Induction Chemotherapy on the Prognosis in Advanced Epithelial Ovarian CancerThe New England Journal of Medicine, 1995
- The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinomaAmerican Journal of Obstetrics and Gynecology, 1994
- The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume Stage III epithelial ovarian cancer: A gynecologic oncology group studyGynecologic Oncology, 1992